Key Points

• Successful industrial and mining IPOs shifted institutional capital toward established operating businesses while several smaller issuers continued reducing or withdrawing planned offerings.
• A surge in technology and healthcare filings signaled strengthening future issuance momentum despite selective investor demand in the current market.
• Limited activity across Europe and Asia reinforced the concentration of global IPO issuance in U.S. capital markets while cross-border filings continued to expand.

US Industrial and Technology Issuance Continues to Drive Global IPO Activity

Global IPO markets remained heavily concentrated in the United States during the week of June 22–June 26, 2026, as institutional investors continued allocating capital toward industrial manufacturing, natural resources, healthcare, and technology issuers. Successful pricings demonstrated that companies with differentiated business models and strategic industry exposure continued attracting investor demand, while several issuers revised or withdrew offerings amid disciplined valuation conditions. Cross-border listings remained another defining theme as Asian companies increasingly targeted U.S. exchanges to access international capital. Meanwhile, Europe recorded limited measurable issuance activity, reinforcing the uneven recovery across global primary markets.

United States — Industrial and Mining Offerings Attract Institutional Capital

The United States remained the primary driver of global IPO activity throughout the week. DPC Holdings (Doncasters Group) completed the week’s largest offering, raising $919 million after pricing 27.9 million shares at $33, above its marketed range following an upsized transaction supported by strong institutional demand. Sinda Ltd. (SIND) also completed a successful NYSE debut, raising $213 million by pricing 17.8 million shares at $12, supported by strategic investments from Franco-Nevada and Fresnillo. Earlier in the week, Forefront Tech Holdings Acquisition Corp. (FTHA) began trading on Nasdaq, opening near its $10.00 IPO price before closing at $9.93, reflecting selective aftermarket performance. The issuance pipeline remained active with new filings and revised offerings from SK hynix, Parabilis Medicines, Kardigan, JuNeng Technology, Deep Fission, Starton Holdings, Albatross Acquisition, and Tino Group, while Kilcoy Global Foods and Helio Corporation withdrew planned offerings. No notable lock-up expirations were identified during the reporting period.

Europe — IPO Markets Remain Quiet as Issuers Continue Waiting

European IPO activity remained subdued throughout the reporting week. No significant new listings, major IPO announcements, or withdrawn transactions were identified across the London Stock Exchange, Euronext, Deutsche Börse, or SIX Swiss Exchange based on the reviewed sources. Compared with the pace of U.S. issuance, European companies continued exercising caution as valuation expectations and market timing remained central considerations. Institutional investors likewise maintained a preference for larger and more liquid transactions available in U.S. markets. The continued absence of meaningful fundraising activity reinforced Europe’s relatively limited contribution to global IPO issuance during the week.

Asia — Cross-Border Technology Listings Continue Building the U.S. Pipeline

Asian IPO activity remained concentrated on companies pursuing access to U.S. capital markets rather than large domestic listings. South Korea’s SK hynix filed for a potential $29.4 billion U.S. IPO, positioning what could become one of the largest semiconductor offerings in recent years while expanding international investor access to one of the world’s leading memory chip manufacturers. In China, JuNeng Technology more than tripled the size of its proposed U.S. offering to $28 million, while Hong Kong-based Tino Group filed for a $29 million U.S. IPO. The week’s activity demonstrated that Asian issuers continue viewing U.S. exchanges as preferred fundraising venues despite ongoing regulatory and geopolitical considerations. Regional activity remained centered on cross-border filings rather than significant domestic exchange issuance.

Markets Will Monitor Whether the Expanding Filing Pipeline Converts Into New Pricings

Attention now shifts toward whether the growing pipeline of healthcare, semiconductor, technology, and acquisition-company filings advances toward successful pricing in the coming weeks. Institutional investors will monitor proposed offerings from SK hynix, Parabilis Medicines, Kardigan, JuNeng Technology, and several acquisition vehicles as indicators of sustained primary market demand. Market participants will also assess whether Europe begins contributing more meaningfully to global issuance volumes or whether U.S. exchanges continue dominating international capital formation through cross-border listings and sector-specific growth opportunities.